In vitro colonic catabolism of orange juice (poly)phenols

Molecular Nutrition and Food Research

Volumn 59, Issue 3, 2015, Pages 465-475

  Pereira Caro, Gema ^a   Borges, Gina ^b   Ky, Isabelle ^c   Ribas, Aleix ^d   Calani, Luca ^e   Del Rio, Daniele ^e   Clifford, Michael N ^f   Roberts, Susan A ^g   Crozier, Alan ^b  

^a IFAPA CENTRO ALAMEDA DEL OBISPO   (Spain)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^e UNIVERSITY OF PARMA   (Italy)

^f UNIVERSITY OF SURREY   (United Kingdom)

^g The Coca Cola Company   (United States)

Author keywords

3 (Phenyl)hydracrylic acids; 3 (Phenyl)propionic acids; Colonic catabolites; Ferulic acid; Flavanones; Human gut microflora; In vitro fecal fermentation

Indexed keywords

COUMARIC ACID; FERULIC ACID; FLAVANONE DERIVATIVE; HESPERETIN; HESPERIDIN; NARINGENIN; POLYPHENOL;

ADULT; BEVERAGE; CHEMISTRY; COLON; FECES; FEMALE; FERMENTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; MALE; MASS FRAGMENTOGRAPHY; METABOLISM; MICROBIOLOGY; SWEET ORANGE;

ADULT; BEVERAGES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CITRUS SINENSIS; COLON; COUMARIC ACIDS; FECES; FEMALE; FERMENTATION; FLAVANONES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HESPERIDIN; HUMANS; IN VITRO TECHNIQUES; MALE; POLYPHENOLS;

EID: 84924003412     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201400779     Document Type: Article

References (53)

1. Del Rio, D., Rodriguez-Mateos, A. M., Spencer, J. P. E., Tognolini, M. et al., Dietary (poly)phenols in health and disease: structures, bioavailability evidence of protective effects and potential mechanisms. Antioxid. Redox Signal. 2013, 18, 1818-1892.
2. Rodriguez-Mateos, A. M., Vauzour, D., Kreuger, C. G., Shanmuganayagam, D. et al., Flavonoids and related compounds, bioavailability bioactivity and impact on human health: an update. Arch. Toxicol. 2014, 88, 1803-1853.
3. Vallejo, F., Larrosa, M., Escudero, E., Zafrilla, M. P. et al., Concentration and solubility of flavanones in orange beverages affect their bioavailability in humans. J. Agric. Food Chem. 2010, 58, 6516-6524.
4. Tomás-Barberán, F., Clifford, M. N., Flavanones, chalcones and dihydrochalcones-nature, occurrence and dietary burden. J. Sci. Food Agric. 2000, 80, 1073-1080.
5. Abad-Garcia, B., Garmón-Lobato, S., Berrueta, L. A., Gallo, B. et al., On-line characterization of 58 phenolic compounds in citrus fruit juices from Spanish cultivars by high-performance liquid chromatography with photodiode array detection coupled to electrospray ionization triple quadrupole mass spectrometry. Talanta 2012, 99, 213-224.
6. Jaganathan, S. K., Vellayappan, M. V., Narasimhan, G., Supriyanto, E., Role of pomegranate and citrus fruit juices in colon cancer prevention. World J. Gastroenterol. 2014, 20, 4618-4625.
7. Chen, H., Ward, M., Graubard, B., Heineman, E. et al., Dietary patterns and adenocarcinoma of the esophagus and distal stomach. Am. J. Clin. Nutr. 2002, 76, 137-144.
8. Levi, F., Pasche, C., Lucchini, F., Bosetti, C. et al., Food groups and oesophageal cancer risk in Vaud, Switzerland. Eur. J. Cancer Prev. 2000, 9, 257-263.
9. Palli, D., Russo, A., Ottini, L., Masala, G. et al., Red meat, family history, and increased risk of gastric cancer with microsatellite instability. Cancer Res. 2001, 61, 5415-5419.
10. McCullough, M., Robertson, A., Jacobs, E., Chao, A. et al., A prospective study of diet and stomach cancer mortality in United States men and women. Cancer Epidemiol. Biomark. Prev. 2001, 10, 1201-1205.
11. Cassidy, A., Rimm, E. B., O'Reilly, É. J., Logroscino, G. et al., Dietary flavonoids and risk of stroke in women. Stroke 2012, 43, 946-951.
12. Morand, C., Dubray, C., Milenkovic, D., Lioger, D. et al., Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers, Am. J. Clin. Nutr. 2011, 93, 73-80.
13. Asgary, S., Keshvari, M., Afshani, M. R., Amiri, M. et al., Effect of fresh orange juice intake on physiological characteristics in healthy volunteers. ISRN Nutr. 2014, 405867. doi: 10.1155/2014/405867
14. Knekt, P., Kumpulainen, J., Järvinen, R., Rissanen, H. et al., Flavonoid intake and risk of chronic diseases. Am. J. Clin. Nutr. 2002, 76, 560-568.
15. Rizza, S., Muniyappa, R., Iantorno, M., Kim J. A. et al., Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome. J. Clin. Endocrinol. Metab. 2011, 96, E782-E792.
16. Mullen, W., Archeveque, M.-A., Edwards, C. A. Matsumoto, H. et al., Bioavailability and metabolism of orange juice flavanones in humans: impact of a full-fat yogurt. J. Agric. Food Chem. 2008, 56, 11157-11164.
17. Borges, G., Lean, M. E. J., Roberts, S. A., Crozier A., Bioavailability of dietary (poly)phenols: a study with ileostomists to discriminate between absorption in small and large intestine. Food Funct. 2013, 4, 754-762.
18. Borges, G., Mullen, W., Mullan, A., Lean, M. E. J. et al., Bioavailability of multiple components following acute ingestion of a polyphenol-rich drink. Mol. Nutr. Food Res. 2010, 54, S268-S277.
19. Jenner, A. M., Rafter, J., Halliwell, B., Human fecal water content of phenolics: the extent of colonic exposure to aromatic compounds. Free Radic. Biol. Med. 2005, 38, 763-772.
20. Roowi, S., Mullen, W., Edwards, C. A., Crozier, A., Yoghurt impacts on the excretion of phenolic acids derived from colonic breakdown of orange juice flavanones in humans. Mol. Nutr. Food Res. 2009, 53, S68-S75.
21. Pereira-Caro, G., Borges, G., van der Hooft, J., Clifford, M. N. et al., Orange juice (poly)phenols are highly bioavailable. Am. J. Clin. Nutr. 2014, 100, 1385-1391.
22. Czank, C., Cassidy, A., Zhang, Q., Morrison, D. J. et al., Human metabolism and elimination of the anthocyanin, cyanidin-3-glucoside: a (13)C-tracer study. Am. J. Clin. Nutr. 2013, 97, 995-1003.
23. Larrosa, M., Luceri, C., Vivoli, E., Pagliuca, C. et al., Polyphenol metabolites from colonic microbiota exert anti-inflammatory activity on different inflammation models. Mol. Nutr. Food Res. 2009, 53, 1044-1054.
24. Williamson, G., Clifford, M. N., Colonic metabolites of berry polyphenols: the missing link to biological activity? Br. J. Nutr. 2010, 104, S48-S66.
25. van Duynhoven, J., Vaughan, E. E., Jacobs, D. M., Kemperman, R. A. et al., Metabolic fate of polyphenols in the human superorganism. Proc. Natl. Acad. Sci. USA 2011, 108, 4531-4538.
26. Verzelloni, E., Pellacani, C., Tagliazucchi, D., Tagliaferri, S. et al., Antiglycative and neuroprotective activity of colon-derived polyphenol catabolites. Mol. Nutr. Food Res. 2011, 55, S35-S43.
27. Hidalgo, M., Martin-Santamaria, S., Recio, I., Sanchez-Moreno, C. et al., Potential anti-inflammatory, anti-adhesive, anti/estrogenic, and angiotensin-converting enzyme inhibitory activities of anthocyanins and their gut metabolites. Genes Nutr. 2012, 7, 295-306.
28. Ludwig, I. A., de Peña, M., Cid, C., Crozier, A., Catabolism of coffee chlorogenic acids by human colonic microbiota. Biofactors 2013, 39, 623-632.
29. Rechner A. R., Smith, M. A., Kuhnle, G., Debnam E. S. et al., Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products. Free Radic. Biol. Med. 2004, 36, 212-225.
30. Grbić-Galić, D., O-demethylation, dehydroxylation, ring-reduction and cleavage of aromatic substrates by Enterobacteriaceae under anaerobic conditions. J. Appl. Bacteriol. 1986, 61, 491-497.
31. 18O-methoxy substituent of 3-methoxybenzoic acid and other unlabeled methoxybenzoic acids by anaerobic bacteria. Appl. Environ. Microbiol. 1988, 54, 1237-1242.
32. Hur, H., Rafii, F., Biotransformation of the isoflavonoids biochanin A, formononetin, and glycitein by Eubacterium limosum. FEMS Microbiol. Lett. 2000, 192, 21-25.
33. Stalmach, A., Mullen, W., Barron, D., Uchida, K. et al., Metabolite profiling of hydroxycinnamate derivatives in plasma and urine following the ingestion of coffee by humans: identification of biomarkers of coffee consumption. Drug Metab. Disp. 2009, 37, 1759-1768.
34. Stalmach, A., Williamson, G., Crozier, A., Impact of dose on the bioavailability of coffee chlorogenic acids in humans. Food Funct. 2014, 5, 1727-1737.
35. Wittemer, S. M., Ploch, M., Windeck, T., Muller, S. C. et al., Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of artichoke leaf extracts in humans. Phytomedicine 2005, 12, 28-38.
36. Lang, R., Dieminger, A., Beusch, A., Lee Y.-M. et al., Bioappearance and pharmacokinetics of bioactives upon coffee consumption. Anal. Bioanal. Chem. 2013, 405, 8487-8503.
37. Shaw, K. N., Trevarthen, J., Exogenous sources of urinary phenol and indole acids. Nature 1958, 182, 797-798.
38. Adams, T. B., McGowen, M. M., Williams, M. C., Cohen, S. M. et al., The FEMA GRAS assessment of aromatic substituted secondary alcohols, ketones, and related esters used as flavor ingredients. Food Chem. Toxicol. 2007, 45, 171-201.
39. Braune, A., Engst, W., Blaut, M., Degradation of neohesperidin dihydrochalcone by human intestinal bacteria. J. Agric. Food Chem. 2005, 53, 1782-1790.
40. Stolz, N., The presence of β-m-hydroxyphenylhydracrylic acid in the urine of patients with ADHD and other neurodegenerative metabolic disorders. MSc Thesis, 2005, South Western University, South Africa.
41. Curzon, G., Pratt, R. T., Origin of urinary resorcinol sulphate. Nature 1964, 204, 383-384.
42. Stoupi, S., Williamson, G., Drynan, J. W., Barron, D. et al., A comparison of the in vitro biotransformation of (-)-epicatechin and procyanidin B2 by human faecal microbiota. Mol. Nutr. Food Res. 2010, 54, 747-759.
43. Das, N. P., Studies on flavonoid metabolism. Absorption and metabolism of (+)-catechin in man. Biochem. Pharmacol. 1971, 20, 3435-3445.
44. Roowi, S., Stalmach, A., Mullen, W., Lean, M. E. J. et al., Green tea flavan-3-ols: colonic degradation and urinary excretion of catabolites by humans. J. Agric. Food Chem. 2010, 58, 1296-1304.
45. van Dorsten, F. A., Grun, C. H., van Velzen, E. J., Jacobs, D. M. et al., The metabolic fate of red wine and grape juice polyphenols in humans assessed by metabolomics. Mol. Nutr. Food Res. 2010, 54, 897-908.
46. Jacobs, D. M., Spiesser, L., Garnier, M., de Roo, N. et al., SPE-NMR metabolite sub-profiling of urine. Anal. Bioanal. Chem. 2012, 404, 2349-2361.
47. Hwang, S.-L., Shih, P.-H., Yen, G.-C., Neuroprotective effects of citrus flavonoids. J. Agric. Food Chem. 2012, 6, 877-885.
48. Coelho, R. C. L. A, Hermsdorff, H. H. M., Bressan, J., Anti-inflammatory properties of orange juice: possible favorable molecular and metabolic effects. Plant Foods Hum. Nutr. 2013, 68, 1-10.
49. Crozier, A., Jaganath, I. B., Clifford, M. N., Dietary phenolics: chemistry, bioavailability and effects on health. Nat. Prod. Rep. 2009, 26, 1001-1043.
50. Cardona, F., Andrés-Lacueva, C., Tulipani, S., Tinahones, F. J. et al., Benefits of polyphenols on gut microbiota and implications in human health. J. Nutr. Biochem. 2013, 24, 1415-1422.
51. Tomás-Barberán F. A., Mine Y., A key to understanding the effects of food bioactives in health, gut microbiota. J. Agric. Food Chem. 2013, 61, 9755-9757.
52. Terao, J., Sies, H., Editorial-Special issue, "Polyphenols and Health". Arch. Biochem. Biophys. 2014, 559, 1-2.
53. Zanotti, I., Dall'Asta, M., Mena, P., Mele, L. et al., Atheroprotective effects of (poly)phenols: focus on cholesterol metabolism. Food Funct. 2015, 6, 13-21.